2026 · 2nd Quarter (Apr 1 - June 30)

ELEVANCE HEALTH, INC.

Filed by MEHLMAN CONSULTING, INC..

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 17, 2026
Income: $90,000.00
Expenses: Not reported
Registrant: MEHLMAN CONSULTING, INC.
Client: ELEVANCE HEALTH, INC.
Filing UUID: 7d6f3c05-88c7-43eb-bcbb-b060709ff757
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to health insurance price transparency. Issues related to prescription drug costs and delivery. Issues related to Surprise Billing.

MMM · Medicare/Medicaid

Medicare Advantage, Medicare Part D, Medicaid Managed Care. Issues related to prescription drug costs and delivery. PBM Reform issues. CY 2027 Medicare Advantage Rate Notice. S. 1105 - No UPCODE Act.

Literal federal measure citations: S. 1105

PHA · Pharmacy

Prescription Drug Pricing.

TAX · Taxation/Internal Revenue Code

Issues related to tax-preferred accounts to help lower the cost of insurance.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.